Lipoapoptosis: Its mechanism and its diseases

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1585, Issue 2-3, 2002, Pages 202-212

  Unger, Roger H ^a,b,d   Orci, Lelio ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cell; Lipoapoptosis; Obesity

Indexed keywords

CYTOCHROME C; LEPTIN; LIPID; NITRIC OXIDE;

ADIPOCYTE; AGING; APOPTOSIS; CELL FUNCTION; CELL POPULATION; DIET; ENZYME ACTIVITY; GENE MUTATION; HEART MUSCLE CELL; HUMAN; LEAN BODY WEIGHT; LIPODYSTROPHY; MUSCLE ATROPHY; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEATOSIS; TISSUE INJURY;

ACYLTRANSFERASES; ADIPOCYTES; AGING; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CASPASES; CERAMIDES; CYTOCHROME C GROUP; FATTY ACIDS; HUMANS; ISLETS OF LANGERHANS; LEPTIN; LIPODYSTROPHY; MUSCLE, SKELETAL; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, CELL SURFACE; SERINE C-PALMITOYLTRANSFERASE; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 0037203345     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00342-6     Document Type: Review

References (73)

1. Hahn von Dorsche H., Schafer H., Titlbach M. Histophysiology of the obesity-diabetes syndrome in sand rats. Adv. Anat. Embryol. Cell Biol. 130:1994;1-95.
2. Unger R.H., Zhou Y.-T. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes. 50:2001;S118-S121.
3. Feuerstein G.Z., Young P.R. Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. Cardiovasc. Res. 45:2000;560-569.
4. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
5. Obata T., Brown G.E., Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPk pathway. Crit. Care Med. 28:2000;N67-N77.
6. Zhou Y.-T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. 97:2000;1784-1789.
7. Shimabukuro M., Zhou Y.-T., Levi M., Unger R.H. Fatty acid-induced beta-cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. 95:1998;2498-2502.
8. Shimabukuro M., Wang M.-Y., Zhou Y.-T., Newgard C.B., Unger R.H. Protection against lipoapoptosis of beta-cell through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. 95:1998;9558-9561.
9. Shimabukuro M., Zhou Y.-T., Lee Y., Unger R.H. Troglitazone lowers islet fat and restores beta-cell function of Zucker Diabetic Fatty rats. J. Biol. Chem. 273:1998;3547-3550.
10. Shimabukuro M., Higa M., Zhou Y.-T., Wang M.-Y., Newgard C.B., Unger R.H. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats: role of serine palmitoyl transferase overexpression. J. Biol. Chem. 273:1998;32487-32490.
11. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
12. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
13. Cikala M., Wilm B., Hobmayer E., Bottger A., David C.N. Identification of caspases and apoptosis in the simple metazoan Hydra. Curr. Biol. 9:1999;959-962.
14. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
15. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 261:1998;1312-1316.
16. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
17. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
18. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
19. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
20. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
21. Liu W., Kim C.N., Yang J., Jimmerson R., Wang K. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell. 86:1996;147-157.
22. Higa M., Zhou Y.-T., Ravazzola M., Baetens D., Orci L., Unger R.H. Troglitazone prevents mitochondrial alterations, beta-cell destruction and diabetes in obese prediabetic rats. Proc. Natl. Acad. Sci. 96:1999;11513-11518.
23. Chiu H.C., Kovacs A., Ford D.A., Hsu F.F., Garcia R., Herrero P., Saffitz J.E., Schaffer J.E. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107:2001;813-822.
24. Weiss B., Stoffel W. Human and murine serine-palmitoyl-CoA transferase. Cloning, expression and characterization of the key enzyme in sphingolipid synthesis. Eur. J. Biochem. 249:1997;239-247.
25. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B. III, Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB). Science. 292:2001;1728-1731.
26. Aikawa R., Nawano M., Gu Y., Katagiri H., Asano T., Zhu W., Nagai R., Komuro I. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of P13 kinase/Akt. Circulation. 102:2000;2873-2879.
27. Navarro P., Valverde A.M., Rohn J.L., Benito M., Lorenzo M. Akt mediates insulin rescue from apoptosis in brown adipocytes: effect of ceramide. Growth Horm. IGF Res. 10:2000;256-266.
28. Basu S., Bayoumy S., Zhang Y., Lozano J., Kolesnick R. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem. 273:1998;30419-30426.
29. DiPaola M., Cocco T., Lorusso M. Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry. 39:2000;6660-6668.
30. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:1998;262-267.
31. Neel J.-V. The "thrifty genotype" in 1998. Nutr. Rev. 57:1999;S2-S9.
32. Seip M., Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. 413:1996;2-28.
33. Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y., Goldstein J.L., Brown M.S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12:1998;3182-3194.
34. Moitra J., Mason M.M., Olive M., Krylov D., Gavrilova O., Marcus-Samuels B., Feigenbaum L., Lee E., Aoyama T., Eckhaus M., Reitman M.L., Vinson C. Life without white fat: a transgenic mouse. Genes Dev. 12:1998;3168-3181.
35. Burant C.F., Sreenan S., Hirano K., Tai T.A., Lohmiller J., Lukens J., Davidson N.O., Ross S., Graves R.A. Troglitazone action is independent of adipose tissue. J. Clin. Invest. 100:1997;2900-2908.
36. Shimomura I., Hammer R.E., Ikemoto S., Brown M.S., Goldstein J.L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 401:1999;73-76.
37. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A.J., DePaoli A.M., Reitman M.L., Taylor S.I., Gorden P., Garg A. Leptin replacement therapy for lipodystrophy. N. Engl. J. Med. 346:2002;570-578.
38. Wang M.-Y., Koyama K., Shimabukuro M., Newgard C.B., Unger R.H. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. 95:1998;714-718.
39. Lee Y., Wang M.-Y., Kakuma T., Wang Z.-W., Babcock E., McCorkle K., Higa M., Zhou Y.-T., Unger R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 276:2001;5629-5630.
40. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270:1995;26746-26749.
41. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271:1996;10697-10703.
42. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 103:2001;1057-1063.
43. Ahima R.S., Flier J. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11:2000;327-332.
44. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:2001;941-946.
45. Unger R.H., Zhou Y.-T., Orci L. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. 96:1999;2391-2395.
46. Unger R.H. Leptin physiology: a second look. Regul. Pept. 92:2000;87-95.
47. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
48. Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
49. Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Substitution at codon 269 (glutamine→proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 224:1996;597-604.
50. Reaven G.M. Role of insulin resistance in human disease. Nutr. Rev. 13:1997;65-66.
51. Shimabukuro M., Koyama K., Chen G., Wang M.-Y., Trieu F., Lee Y., Newgard C.B., Unger R.H. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. 94:1997;4637-4641.
52. Keller H., Mahfoudi A., Dreyer C., Hihi A.K., Medin J., Ozato K., Wahli W. Peroxisome proliferator-activated receptors and lipid metabolism. Ann. N.Y. Acad. Sci. 684:1993;157-173.
53. Zhou Y.-T., Wang Z.-W., Higa M., Newgard C.B., Unger R.H. Reversing adipocyte differentiation: implications for treatment of obesity. Proc. Natl. Acad. Sci. 96:1999;2391-2395.
54. Zhou Y.-T., Shimabukuro M., Koyama K., Lee Y., Wang M.-Y., Trieu F., Newgard C.B., Unger R.H. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc. Natl. Acad. Sci. 94:1997;6386-6390.
55. Tontonoz P., Kim J.B., Graves R.A., Spiegelman B.M. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13:1993;4753-4759.
56. Wang X., Sato R., Brown M.S., Hua X., Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77:1994;53-62.
57. Kliewer S.A., Forman B.M., Blumberg B., Ong I.S., Borgmeyer U., Mangelsdorf D., Umesono K., Evans R.M. Differential expansion of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. 91:1994;7355-7359.
58. Kakuma T., Lee Y., Higa M., Wang Z.-W., Pan W., Shimomura I., Unger R.H. Leptin, troglitazone and the expression of sterol regulatory element binding proteins in liver and pancreas. Proc. Natl. Acad. Sci. 97:2000;8536-8541.
59. Zhou Y.-T., Shimabukuro M., Lee Y., Koyama K., Higa M., Ferguson T., Unger R.H. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes. 47:1998;1904-1908.
60. Lee Y., Hirose H., Zhou Y.-T., Esser V., McGarry J.D., Unger R.H. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes. 46:1997;408-413.
61. Unger R.H., Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15:2001;312-321.
62. Shimabukuro M., Koyama K., Lee Y., Unger R.H. Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1B cytotoxicity. J. Clin. Invest. 100:1997;1750-1754.
63. Gudz T.I., Tserng K.Y., Hoppel C.L. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J. Biol. Chem. 272:1997;24154-24158.
64. Kenedy S.G., Wagner A.J., Conzen S.D., Jordan J., Bellacosa A., Tsichllis P.N., Hay N. The PI 3-kinase/Akt signaling pathway delivers an antiapoptotic signal. Genes Dev. 11:1997;701-713.
65. Kulik G., Klippel A., Weber M.J. Antiapoptotic signaling by the insulin-like growth factor I receptor phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1997;1595-1606.
66. Zhou H., Summers S.A., Birnbaum M.J., Pittman R.N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem. 273:1998;16568-16575.
67. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276:2001;14890-14895.
68. Das U.N. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins, Leukot. Essent. Fat. Acids. 61:1999;157-163.
69. Dyntar D., Eppenberger-Eberhardt M., Maedler K., Pruschy M., Eppenberger H.M., Spinas G.A., Donath M.Y. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes. 50:2001;2105-2113.
70. Vigouroux C., Gharakhanian S., Salhi Y., Nguyen T.H., Chevenne D., Capeau J., Rosenbaum W. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabetes Metab. 25:1999;225-232.
71. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
72. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.M., Basdevant A., Bougneres P., Lebouc Y., Froguel P., Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:1998;398-401.
73. Wang Z.-W., Pan W., Lee Y., Kakuma T., Zhou Y.-T., Unger R.H. The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 15:2001;108-114.